Comparative toxicities and pharmacokinetics of intrathecal lipid (amphotericin B colloidal dispersion) and conventional deoxycholate formulations of amphotericin B in rabbits
Kv. Clemons et al., Comparative toxicities and pharmacokinetics of intrathecal lipid (amphotericin B colloidal dispersion) and conventional deoxycholate formulations of amphotericin B in rabbits, ANTIM AG CH, 45(2), 2001, pp. 612-615
The lipid formulation of amphotericin B, Amphotec (ABCD), has not been used
intrathecally. After a single intrathecal dose or after four doses, conven
tionally formulated deoxycholate amphotericin B (AMB) (Fungizone) resulted
in higher levels of amphotericin B in the cerebrospinal fluid of rabbits th
an did ABCD. Clinically and histologically, ABCD was about threefold less t
oxic than AMB after a single dose and 3- to 30-fold less toxic after multip
le dosing. These data are encouraging for the potential use of ABCD as an i
ntrathecal treatment.